What is Axon Enterprise's (formerly TASER International) primary business and revenue model?

Axon Enterprise's primary business is the development, manufacture, and sale of Conducted Electrical Weapons (CEWs) under the TASER brand, and integrated hardware and software solutions for video and digital evidence management, notably the AXON body cameras and EVIDENCE.com platform. Revenue is generated from the sale of these products, as well as from recurring service fees for EVIDENCE.com subscriptions and extended warranties.

How did the company perform financially in 2013 compared to 2012?

In 2013, Axon Enterprise reported a net sales increase of 20.1% to $137.8 million, with significant growth in both its TASER Weapons segment and its EVIDENCE.com & Video segment. Net income rose from $14.7 million in 2012 to $18.2 million in 2013, with gross margins improving to 62.3%. This strong financial performance was supported by new product introductions and the increasing adoption of its evidence management solutions.

What are the key growth drivers for Axon Enterprise?

The key growth drivers for Axon Enterprise are the continued innovation and sales of its TASER CEW products, particularly the newer models like the X26P and X2. Additionally, the rapidly expanding market for law enforcement body-worn cameras and digital evidence management systems, represented by the AXON products and EVIDENCE.com platform, is a major growth driver. The company is also focused on increasing its international market penetration.

What are the main risks the company faces?

The company faces several risks, including its material dependence on the law enforcement market's acceptance of its products, the risk of defects in its products, potential security breaches of its EVIDENCE.com platform, delays in product development and sales cycles, intense competition, and regulatory challenges in various jurisdictions. Litigation, particularly related to product liability claims, also presents a significant ongoing risk.

AXON 10-K FY2013 Annual Report — Revenue, Net Income, EPS

Summary

Axon Enterprise, Inc. (formerly TASER International, Inc.) demonstrated robust revenue growth in 2013, driven by strong performance in both its TASER Weapons segment and its burgeoning EVIDENCE.com & Video segment. The company reported a 20.1% increase in net sales, reaching $137.8 million. This growth was primarily fueled by the introduction of new products like the TASER X26P and continued adoption of the AXON body cameras and EVIDENCE.com platform by law enforcement agencies. Financially, the company achieved significant profitability improvements, with net income rising to $18.2 million in 2013, up from $14.7 million in 2012. This performance was supported by improved gross margins and effective management of operating expenses. The company's strategic focus on expanding its video evidence solutions and increasing market penetration, both domestically and internationally, appears to be yielding positive results, positioning it for continued growth in the evolving landscape of law enforcement technology.

Financial Highlights

50 data points

Beta

Revenue

$136.12M

0.6% Gross Margin

Net Income

$18.24M

0.1% Net Margin

EPS (Diluted)

$0.34

Total Assets

$148.38M

Cash & Equivalents

$42.27M

Free Cash Flow

$30.64M

Financial Statements

Beta

Revenue	$136.12M
Cost of Revenue	$51.99M
Gross Profit	$85.84M
R&D Expenses	$9.89M
SG&A Expenses	$46.56M
Operating Expenses	$57.90M
Operating Income	$27.95M
Net Income	$18.24M
EPS (Basic)	$0.35
EPS (Diluted)	$0.34
Shares Outstanding (Basic)	51.88M
Shares Outstanding (Diluted)	54.15M

Key Highlights

1Net sales increased by 20.1% to $137.8 million in 2013, up from $114.8 million in 2012, indicating strong market demand.
2The EVIDENCE.com & Video segment experienced significant growth, with net sales increasing by 81.8% to $10.4 million in 2013, demonstrating successful expansion into new technology areas.
3Net income improved by $3.5 million to $18.2 million in 2013, compared to $14.7 million in 2012, reflecting enhanced profitability.
4Gross margin improved to 62.3% in 2013 from 59.0% in 2012, driven by favorable product mix and operational efficiencies.
5The company repurchased $25.0 million of its common stock in 2013, indicating a commitment to returning value to shareholders.
6Bookings for the EVIDENCE.com and AXON product lines saw a substantial increase of 282% to $14.5 million in 2013, signaling strong future revenue potential for these segments.
7Despite a challenging litigation environment, the company managed its legal expenses effectively, with litigation judgment expenses decreasing from $3.3 million in 2011 to a net recovery of $2.2 million in 2012, and then rising to $1.5 million in 2013.

AXON ENTERPRISE, INC. Annual Report, Year Ended Dec 31, 2013

Summary

Financial Highlights

Key Highlights

Frequently Asked Questions